UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $760,154 | -7.7% | 8,839 | 0.0% | 0.00% | – |
Q2 2023 | $823,795 | +98204.9% | 8,839 | 0.0% | 0.00% | – |
Q1 2023 | $838 | -7.0% | 8,839 | -1.4% | 0.00% | – |
Q4 2022 | $901 | -99.9% | 8,964 | -8.3% | 0.00% | – |
Q3 2022 | $834,000 | +0.4% | 9,774 | +1.0% | 0.00% | – |
Q2 2022 | $831,000 | -19.1% | 9,676 | -17.0% | 0.00% | – |
Q1 2022 | $1,027,000 | -17.5% | 11,658 | +1.1% | 0.00% | – |
Q4 2021 | $1,245,000 | -0.3% | 11,533 | -17.8% | 0.00% | – |
Q3 2021 | $1,249,000 | -6.2% | 14,029 | -10.4% | 0.00% | – |
Q2 2021 | $1,331,000 | +10.2% | 15,649 | +12.2% | 0.00% | – |
Q1 2021 | $1,208,000 | -2.9% | 13,952 | -5.5% | 0.00% | – |
Q4 2020 | $1,244,000 | +13.0% | 14,758 | +7.1% | 0.00% | – |
Q3 2020 | $1,101,000 | -6.0% | 13,781 | +4.3% | 0.00% | – |
Q2 2020 | $1,171,000 | -7.6% | 13,207 | -2.1% | 0.00% | -100.0% |
Q1 2020 | $1,268,000 | +74.4% | 13,490 | +100.2% | 0.00% | – |
Q4 2019 | $727,000 | -41.3% | 6,738 | -47.8% | 0.00% | -100.0% |
Q3 2019 | $1,238,000 | -5.4% | 12,918 | -5.5% | 0.00% | 0.0% |
Q2 2019 | $1,309,000 | – | 13,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |